MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Daytime Sleepiness Effects on Motor Symptoms in De Novo Parkinson’s Disease

E. Bayram, R. Yilmaz, K. Longardner, M. Akbostanci, I. Litvan (La Jolla, CA, USA)

Meeting: 2019 International Congress

Abstract Number: 797

Keywords: Excessive daytime sleepiness(EDS), Gait disorders: Etiology and Pathogenesis, Parkinsonism

Session Information

Date: Tuesday, September 24, 2019

Session Title: Parkinsonisms and Parkinson-Plus

Session Time: 1:45pm-3:15pm

Location: Agora 3 West, Level 3

Objective: To investigate whether daytime sleepiness in newly diagnosed Parkinson’s disease (PD) patients predicts future dependency.

Background: Excessive daytime sleepiness (EDS) is one of the common early non-motor symptoms of PD affecting 33.9% of patients (1). Although EDS does not seem to be associated with motor impairment in de novo PD (2), longitudinal studies revealed associations between EDS and postural instability-gait disorder (PIGD) motor phenotype (3). As the PIGD phenotype is a predictor of more rapid disability development in PD (4), daytime sleepiness may be related to future functional dependency.

Method: Data of 158 de novo PD patients with baseline and year six evaluations was obtained from Parkinson Progression Markers Initiative (PPMI). Functional dependency was determined by a score below 80 on Modified Schwab and England Activities of Daily Living Scale (ADL); as 80 is the last score for complete independency. Baseline demographics, disease characteristics, and daytime sleepiness scores (assessed by Epworth Sleepiness Scale, ESS) were compared between patients who were dependent or independent at 6th year. Association between baseline ESS scores and dependency at year six was evaluated with logistic regression. Other covariates included in the  model were; mood and autonomic dysfunction due to their associations with daytime sleepiness in de novo PD (2); age, cognition (assessed by Montreal Cognitive Assessment, MoCA), motor severity and phenotype due to previous association between PIGD and disability in PD (5).

Results: Out of 158 functionally independent PD patients at baseline, 17.1 % were dependent at the 6th year. Baseline differences between groups are summarized in Table 1. Patients who became dependent at year six were older at baseline when newly diagnosed with PD, and had higher scores on sleepiness and autonomic symptoms scales. Older age and higher ESS score at baseline were associated with dependency at 6th year (Table 2). None of the other factors were significant.

Conclusion: Higher baseline daytime sleepiness scores in de novo PD predicts with dependency at 6th year. Daytime sleepiness is an important symptom to not be overlooked, and determining its pathophysiology may be helpful to delay future dependency.

table1

table 2

References: 1. Chen H, Zhao EJ, Zhang W, et al. Meta-analyses on prevalence of selected Parkinson’s nonmotor symptoms before and after diagnosis. Transl Neurodegener. 2015;4(1):1. doi:10.1186/2047-9158-4-1 2. Simuni T, Caspell-Garcia C, Coffey C, et al. Correlates of excessive daytime sleepiness in de novo Parkinson’s disease: A case control study. Mov Disord. 2015;30(10):1371-1381. doi:10.1002/mds.26248 3. Amara AW, Chahine LM, Caspell-Garcia C, et al. Longitudinal assessment of excessive daytime sleepiness in early Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2017;88(8):653-662. doi:10.1136/jnnp-2016-315023 4. Post B, Merkus MP, de Haan RJ, Speelman JD, CARPA Study Group. Prognostic factors for the progression of Parkinson’s disease: A systematic review. Mov Disord. 2007;22(13):1839-1851. doi:10.1002/mds.21537 5. Macleod AD, Counsell CE. Predictors of functional dependency in Parkinson’s disease. Mov Disord. 2016;31(10):1482-1488. doi:10.1002/mds.26751

To cite this abstract in AMA style:

E. Bayram, R. Yilmaz, K. Longardner, M. Akbostanci, I. Litvan. Daytime Sleepiness Effects on Motor Symptoms in De Novo Parkinson’s Disease [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/daytime-sleepiness-effects-on-motor-symptoms-in-de-novo-parkinsons-disease/. Accessed May 13, 2025.
  • Tweet
  • Email
  • Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/daytime-sleepiness-effects-on-motor-symptoms-in-de-novo-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley